Wildflower Brands Inc WLDFF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.07 / $0.11
- Market Cap
- $139.33
- Volume/Avg
- 2,000 / 1,486
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Wildflower Brands Inc primarily focuses on developing and designing products in the cannabis and healthcare sectors. Wildflower sells its CBD+ products online and to retailers throughout the US and also produces and markets its THC products in regulated cannabis jurisdictions. The company's operations and assets are located in Canada and the USA.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
- Website
- http://www.wildflower.ca
Valuation
|
Metric
|
WLDFF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
WLDFF
Financial Strength
|
Metric
|
WLDFF
|
|---|---|
Quick Ratio | 0.30 |
Current Ratio | 0.67 |
Interest Coverage | −1.87 |
Quick Ratio
WLDFF
Profitability
|
Metric
|
WLDFF
|
|---|---|
Return on Assets (Normalized) | −6.83% |
Return on Equity (Normalized) | −14.78% |
Return on Invested Capital (Normalized) | −3.80% |
Return on Assets
WLDFF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Mytrprhzqw | Crhkt | $82.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Bgtzcthgq | Rlrvwz | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Nsdygvl | Svhrg | $41.4 Bil | |||
| Viatris Inc
VTRS
| Hmnctxlf | Lqn | $14.4 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Cbjhgyw | Crmv | $13.7 Bil | |||
| Catalent Inc
CTLT
| Zdyvcltyc | Vzsxd | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Yhjmyckxf | Lsbtq | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Dmbcqnft | Ljtxzc | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Mvvmkccb | Qzdc | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Fkcbrnfng | Xnft | $2.7 Bil |